Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Dezawa, M; Takano, M; Negishi, H; Mo, XF; Oshitari, T; Sawada, H
   Gene transfer into retinal ganglion cells by in vivo electroporation: a new approach
   MICRON
   
   M. Dezawa et al., "Gene transfer into retinal ganglion cells by in vivo electroporation: a new approach", MICRON, 33(1), 2002, pp. 1-6
2. Chirila, TV; Rakoczy, PE; Garrett, KL; Lou, X; Constable, IJ
   The use of synthetic polymers for delivery of therapeutic antisense oligodeoxynucleotides
   BIOMATERIALS
   
   T.V. Chirila et al., "The use of synthetic polymers for delivery of therapeutic antisense oligodeoxynucleotides", BIOMATERIAL, 23(2), 2002, pp. 321-342
3. Molinier-Frenkel, V; Lengagne, R; Gaden, F; Hong, SS; Choppin, J; Gahery-Segard, H; Boulanger, P; Guillet, JG
   Adenovirus hexon protein is a potent adjuvant for activation of a cellularimmune response
   JOURNAL OF VIROLOGY
   
   V. Molinier-Frenkel et al., "Adenovirus hexon protein is a potent adjuvant for activation of a cellularimmune response", J VIROLOGY, 76(1), 2002, pp. 127-135
4. Gotsman, I; Israeli, D; Alper, R; Rabbani, E; Engelhardt, D; Ilan, Y
   Induction of immune tolerance toward tumor-associated-antigens enables growth of human hepatoma in mice
   INTERNATIONAL JOURNAL OF CANCER
   
   I. Gotsman et al., "Induction of immune tolerance toward tumor-associated-antigens enables growth of human hepatoma in mice", INT J CANC, 97(1), 2002, pp. 52-57
5. Merten, OW; Cruz, PE; Rochette, C; Geny-Fiamma, C; Bouquet, C; Goncalves, D; Danos, O; Carrondo, MJT
   Comparison of different bioreactor systems for the production of high titer retroviral vectors
   BIOTECHNOLOGY PROGRESS
   
   O.W. Merten et al., "Comparison of different bioreactor systems for the production of high titer retroviral vectors", BIOTECH PR, 17(2), 2001, pp. 326-335
6. Liu, P; Kalajzic, I; Stover, ML; Rowe, DW; Lichtler, AC
   Human bone marrow stromal cells are efficiently transduced by vesicular stomatitis virus-pseudotyped retrovectors without affecting subsequent osteoblastic differentiation
   BONE
   
   P. Liu et al., "Human bone marrow stromal cells are efficiently transduced by vesicular stomatitis virus-pseudotyped retrovectors without affecting subsequent osteoblastic differentiation", BONE, 29(4), 2001, pp. 331-335
7. Musgrave, DS; Pruchnic, R; Wright, V; Bosch, P; Ghivizzani, SC; Robbins, PD; Huard, J
   The effect of bone morphogenetic protein-2 expression on the early fate ofskeletal muscle-derived cells
   BONE
   
   D.S. Musgrave et al., "The effect of bone morphogenetic protein-2 expression on the early fate ofskeletal muscle-derived cells", BONE, 28(5), 2001, pp. 499-506
8. Uusitalo, H; Rantakokko, J; Ahonen, M; Jamsa, T; Tuukkanen, J; Kahari, VM; Vuorio, E; Aro, HT
   A metaphyseal defect model of the femur for studies of murine bone healing
   BONE
   
   H. Uusitalo et al., "A metaphyseal defect model of the femur for studies of murine bone healing", BONE, 28(4), 2001, pp. 423-429
9. Hawke, TJ; Garry, DJ
   Myogenic satellite cells: physiology to molecular biology
   JOURNAL OF APPLIED PHYSIOLOGY
   
   T.J. Hawke e D.J. Garry, "Myogenic satellite cells: physiology to molecular biology", J APP PHYSL, 91(2), 2001, pp. 534-551
10. Lang, S; Zeidler, R; Pauli, C; Andratschke, M; Wollenberg, B
    Targeting head and neck cancer by IL-2-mediated gene therapy: From bench to bedside - A review.
    LARYNGO-RHINO-OTOLOGIE
    
    S. Lang et al., "Targeting head and neck cancer by IL-2-mediated gene therapy: From bench to bedside - A review.", LARY RH OTO, 80(4), 2001, pp. 191-195
11. Haviv, YS; Blackwell, J
    Transcriptional regulation in cancer gene therapy
    ISRAEL MEDICAL ASSOCIATION JOURNAL
    
    Y.S. Haviv e J. Blackwell, "Transcriptional regulation in cancer gene therapy", ISR MED ASS, 3(7), 2001, pp. 517-522
12. Cohen, ZR; Duvdevani, R; Nass, D; Hadani, M; Ram, Z
    Intraarterial delivery of genetic vectors for the treatment of malignant brain tumors
    ISRAEL MEDICAL ASSOCIATION JOURNAL
    
    Z.R. Cohen et al., "Intraarterial delivery of genetic vectors for the treatment of malignant brain tumors", ISR MED ASS, 3(2), 2001, pp. 117
13. Segura, T; Shea, LD
    Materials for non-viral gene delivery
    ANNUAL REVIEW OF MATERIALS RESEARCH
    
    T. Segura e L.D. Shea, "Materials for non-viral gene delivery", ANN REV M R, 31, 2001, pp. 25-46
14. Kaplan, SH; Greenfield, S; Connolly, GA; Barlow, SE; Grand, R
    Methodologic issues in the conduct and interpretation of pediatric effectiveness research
    AMBULATORY PEDIATRICS
    
    S.H. Kaplan et al., "Methodologic issues in the conduct and interpretation of pediatric effectiveness research", AMBU PEDIAT, 1(1), 2001, pp. 63-70
15. Bhardwaj, G; Murdoch, B; Wu, D; Baker, DP; Williams, KP; Chadwick, K; Ling, LE; Karanu, FN; Bhatia, M
    Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation
    NATURE IMMUNOLOGY
    
    G. Bhardwaj et al., "Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation", NAT IMMUNOL, 2(2), 2001, pp. 172-180
16. Wolff, RA
    Novel therapies for pancreatic cancer
    CANCER JOURNAL
    
    R.A. Wolff, "Novel therapies for pancreatic cancer", CANCER J, 7(4), 2001, pp. 349-358
17. Pfeifer, A; Verma, IM
    Gene therapy: Promises and problems
    ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS
    
    A. Pfeifer e I.M. Verma, "Gene therapy: Promises and problems", ANN REV GEN, 2, 2001, pp. 177-211
18. Factor, P
    Gene therapy for acute diseases
    MOLECULAR THERAPY
    
    P. Factor, "Gene therapy for acute diseases", MOL THER, 4(6), 2001, pp. 515-524
19. Hartigan-O'Connor, D; Kirk, CJ; Crawford, R; Mule, JJ; Chamberlain, JS
    Immune evasion by muscle-specific gene expression in dystrophic muscle
    MOLECULAR THERAPY
    
    D. Hartigan-O'Connor et al., "Immune evasion by muscle-specific gene expression in dystrophic muscle", MOL THER, 4(6), 2001, pp. 525-533
20. Favre, D; Provost, N; Blouin, V; Blacho, G; Cherel, Y; Salvetti, A; Moullier, P
    Immediate and long-term safety of recombinant adeno-associated virus injection into the nonhuman primate muscle
    MOLECULAR THERAPY
    
    D. Favre et al., "Immediate and long-term safety of recombinant adeno-associated virus injection into the nonhuman primate muscle", MOL THER, 4(6), 2001, pp. 559-566
21. Arruda, VR; Fields, PA; Milner, R; Wainwright, L; De Miguel, MP; Donovan, PJ; Herzog, RW; Nichols, TC; Biegel, JA; Razavi, M; Dake, M; Huff, D; Flake, AW; Couto, L; Kay, MA; High, KA
    Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in males
    MOLECULAR THERAPY
    
    V.R. Arruda et al., "Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in males", MOL THER, 4(6), 2001, pp. 586-592
22. Williams, JC; Stone, D; Smith-Arica, JR; Morris, ID; Lowenstein, PR; Castro, MG
    Regulated, adenovirus-mediated delivery of tyrosine hydroxylase suppressesgrowth of estrogen-induced pituitary prolactinomas
    MOLECULAR THERAPY
    
    J.C. Williams et al., "Regulated, adenovirus-mediated delivery of tyrosine hydroxylase suppressesgrowth of estrogen-induced pituitary prolactinomas", MOL THER, 4(6), 2001, pp. 593-602
23. Peters, AHFM; Drumm, J; Ferrell, C; Roth, DA; Roth, DM; McCaman, M; Novak, PL; Friedman, J; Engler, R; Braun, RE
    Absence of germline infection in male mice following intraventricular injection of adenovirus
    MOLECULAR THERAPY
    
    A.H.F.M. Peters et al., "Absence of germline infection in male mice following intraventricular injection of adenovirus", MOL THER, 4(6), 2001, pp. 603-613
24. Sanftner, LHM; Abel, H; Hauswirth, WW; Flannery, JG
    Glial cell line derived neurotrophic factor delays photoreceptor degeneration in a transgenic rat model of retinitis pigmentosa
    MOLECULAR THERAPY
    
    L.H.M. Sanftner et al., "Glial cell line derived neurotrophic factor delays photoreceptor degeneration in a transgenic rat model of retinitis pigmentosa", MOL THER, 4(6), 2001, pp. 622-629
25. Rubinchik, S; Wang, D; Yu, H; Fan, F; Luo, M; Norris, JS; Dong, JY
    A complex adenovirus vector that delivers FASL-GFP with combined prostate-specific and tetracycline-regulated expression
    MOLECULAR THERAPY
    
    S. Rubinchik et al., "A complex adenovirus vector that delivers FASL-GFP with combined prostate-specific and tetracycline-regulated expression", MOL THER, 4(5), 2001, pp. 416-426
26. Unsinger, J; Kroger, A; Hauser, H; Wirth, D
    Retroviral vectors for the transduction of autoregulated, bidirectional expression cassettes
    MOLECULAR THERAPY
    
    J. Unsinger et al., "Retroviral vectors for the transduction of autoregulated, bidirectional expression cassettes", MOL THER, 4(5), 2001, pp. 484-489
27. Guibinga, GH; Ebihara, S; Nalbantoglu, J; Holland, P; Karpati, G; Petrof, BJ
    Forced myofiber regeneration promotes dystrophin gene transfer and improved muscle function despite advanced disease in old dystrophic mice
    MOLECULAR THERAPY
    
    G.H. Guibinga et al., "Forced myofiber regeneration promotes dystrophin gene transfer and improved muscle function despite advanced disease in old dystrophic mice", MOL THER, 4(5), 2001, pp. 499-507
28. Wu, JC; Sundaresan, G; Iyer, M; Gambhir, SS
    Noninvasive optical imaging of firefly luciferase reporter gene expressionin skeletal muscles of living mice
    MOLECULAR THERAPY
    
    J.C. Wu et al., "Noninvasive optical imaging of firefly luciferase reporter gene expressionin skeletal muscles of living mice", MOL THER, 4(4), 2001, pp. 297-306
29. Ko, KS; Lee, M; Koh, JJ; Kim, SW
    Combined administration of plasmids encoding IL-4 and IL-10 prevents the development of autoimmune diabetes in nonobese diabetic mice
    MOLECULAR THERAPY
    
    K.S. Ko et al., "Combined administration of plasmids encoding IL-4 and IL-10 prevents the development of autoimmune diabetes in nonobese diabetic mice", MOL THER, 4(4), 2001, pp. 313-316
30. Satkauskas, S; Bureau, MF; Mahfoudi, A; Mir, LM
    Slow accumulation of plasmid in muscle cells: Supporting evidence for a mechanism of DNA uptake by receptor-mediated endocytosis
    MOLECULAR THERAPY
    
    S. Satkauskas et al., "Slow accumulation of plasmid in muscle cells: Supporting evidence for a mechanism of DNA uptake by receptor-mediated endocytosis", MOL THER, 4(4), 2001, pp. 317-323
31. Sanchez-Pernaute, R; Harvey-White, J; Cunningham, J; Bankiewicz, KS
    Functional effect of adeno-associated virus mediated gene transfer of aromatic L-amino acid decarboxylase into the striatum of 6-OHDA-lesioned rats
    MOLECULAR THERAPY
    
    R. Sanchez-Pernaute et al., "Functional effect of adeno-associated virus mediated gene transfer of aromatic L-amino acid decarboxylase into the striatum of 6-OHDA-lesioned rats", MOL THER, 4(4), 2001, pp. 324-330
32. Richard, E; Mendez, M; Mazurier, F; Morel, C; Costet, P; Xia, P; Fontanellas, A; Geronimi, F; Cario-Andre, M; Taine, L; Ged, C; Malik, P; de Verneuil, H; Moreau-Gaudry, F
    Gene therapy of a mouse model of protoporphyria with a self-inactivating erythroid-specific lentiviral vector without preselection
    MOLECULAR THERAPY
    
    E. Richard et al., "Gene therapy of a mouse model of protoporphyria with a self-inactivating erythroid-specific lentiviral vector without preselection", MOL THER, 4(4), 2001, pp. 331-338
33. Lipinski, KS; Djeha, AH; Ismail, T; Mountain, A; Young, LS; Wrighton, CJ
    High-level, beta-catenin/TCF-dependent transgene expression in secondary colorectal cancer tissue
    MOLECULAR THERAPY
    
    K.S. Lipinski et al., "High-level, beta-catenin/TCF-dependent transgene expression in secondary colorectal cancer tissue", MOL THER, 4(4), 2001, pp. 365-371
34. Zhu, YH; Feuer, G; Day, SL; Wrzesinski, S; Planelles, V
    Multigene lentiviral vectors based on differential splicing and translational control
    MOLECULAR THERAPY
    
    Y.H. Zhu et al., "Multigene lentiviral vectors based on differential splicing and translational control", MOL THER, 4(4), 2001, pp. 375-382
35. Duan, DS; Yue, YP; Engelhardt, JF
    Expanding AAV packaging capacity with trans-splicing or overlapping vectors: A quantitative comparison
    MOLECULAR THERAPY
    
    D.S. Duan et al., "Expanding AAV packaging capacity with trans-splicing or overlapping vectors: A quantitative comparison", MOL THER, 4(4), 2001, pp. 383-391
36. Park, F; Kay, MA
    Modified HIV-1 based lentiviral vectors have an effect on viral transduction efficiency and gene expression in vitro and in vivo
    MOLECULAR THERAPY
    
    F. Park e M.A. Kay, "Modified HIV-1 based lentiviral vectors have an effect on viral transduction efficiency and gene expression in vitro and in vivo", MOL THER, 4(3), 2001, pp. 164-173
37. Nicklin, SA; Buening, H; Dishart, KL; de Alwis, M; Girod, A; Hacker, U; Thrasher, AJ; Ali, RR; Hallek, M; Baker, AH
    Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells
    MOLECULAR THERAPY
    
    S.A. Nicklin et al., "Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells", MOL THER, 4(3), 2001, pp. 174-181
38. Sung, MW; Yeh, HC; Thung, SN; Schwartz, ME; Mandeli, JP; Chen, SH; Woo, SLC
    Intratumoral adenovirus-mediated suicide gene transfer for hepatic metastases from colorectal adenocarcinoma: Results of a phase I clinical trial
    MOLECULAR THERAPY
    
    M.W. Sung et al., "Intratumoral adenovirus-mediated suicide gene transfer for hepatic metastases from colorectal adenocarcinoma: Results of a phase I clinical trial", MOL THER, 4(3), 2001, pp. 182-191
39. Hemminki, A; Belousova, N; Zinn, KR; Liu, B; Wang, MH; Chaudhuri, TR; Rogers, BE; Buchsbaum, DJ; Siegal, GP; Barnes, MN; Gomez-Navarro, J; Curiel, DT; Alvarez, RD
    An adenovirus with enhanced infectivity mediates molecular chemotherapy ofovarian cancer cells and allows imaging of gene expression
    MOLECULAR THERAPY
    
    A. Hemminki et al., "An adenovirus with enhanced infectivity mediates molecular chemotherapy ofovarian cancer cells and allows imaging of gene expression", MOL THER, 4(3), 2001, pp. 223-231
40. Okimoto, T; Friedmann, T; Miyanohara, A
    VSV-G envelope glycoprotein forms complexes with plasmid DNA and MLV retrovirus-like particles in cell-free conditions and enhances DNA transfection
    MOLECULAR THERAPY
    
    T. Okimoto et al., "VSV-G envelope glycoprotein forms complexes with plasmid DNA and MLV retrovirus-like particles in cell-free conditions and enhances DNA transfection", MOL THER, 4(3), 2001, pp. 232-238
41. Honigman, A; Zeira, E; Ohana, P; Abramovitz, R; Tavor, E; Bar, I; Zilberman, Y; Rabinovsky, R; Gazit, D; Joseph, A; Panet, A; Shai, E; Palmon, A; Laster, M; Galun, E
    Imaging transgene expression in live animals
    MOLECULAR THERAPY
    
    A. Honigman et al., "Imaging transgene expression in live animals", MOL THER, 4(3), 2001, pp. 239-249
42. Griffith, TS; Broghammer, EL
    Suppression of tumor growth following intralesional therapy with TRAIL recombinant adenovirus
    MOLECULAR THERAPY
    
    T.S. Griffith e E.L. Broghammer, "Suppression of tumor growth following intralesional therapy with TRAIL recombinant adenovirus", MOL THER, 4(3), 2001, pp. 257-266
43. Inazawa, T; Tanabe, T; Yamada, H; Nakaoka, T; Hashimoto, Y; Yamasaki, T; Kotaki, H; Tani, K; Asano, S; Yamashita, N
    Glucocorticoid-regulated expression of exogenous human growth hormone genein rats
    MOLECULAR THERAPY
    
    T. Inazawa et al., "Glucocorticoid-regulated expression of exogenous human growth hormone genein rats", MOL THER, 4(3), 2001, pp. 267-272
44. Thaler, S; Schnierle, BS
    A packaging cell line generating CD4-specific retroviral vectors for efficient gene transfer into primary human T-helper lymphocytes
    MOLECULAR THERAPY
    
    S. Thaler e B.S. Schnierle, "A packaging cell line generating CD4-specific retroviral vectors for efficient gene transfer into primary human T-helper lymphocytes", MOL THER, 4(3), 2001, pp. 273-279
45. Peng, HR; Chen, ST; Wergedal, JE; Polo, JM; Yee, JK; Lau, KHW; Baylink, DJ
    Development of an MFG-based retroviral vector system for secretion of highlevels of functionally active human BMP4
    MOLECULAR THERAPY
    
    H.R. Peng et al., "Development of an MFG-based retroviral vector system for secretion of highlevels of functionally active human BMP4", MOL THER, 4(2), 2001, pp. 95-104
46. Puttaraju, M; DiPasquale, J; Baker, CC; Mitchell, LG; Garcia-Blanco, MA
    Messenger RNA repair and restoration of protein function by spliceosome-mediated RNA trans-splicing
    MOLECULAR THERAPY
    
    M. Puttaraju et al., "Messenger RNA repair and restoration of protein function by spliceosome-mediated RNA trans-splicing", MOL THER, 4(2), 2001, pp. 105-114
47. Boyle, MP; Enke, RA; Adams, RJ; Guggino, WB; Zeitlin, PL
    In utero AAV-mediated gene transfer to rabbit pulmonary epithelium
    MOLECULAR THERAPY
    
    M.P. Boyle et al., "In utero AAV-mediated gene transfer to rabbit pulmonary epithelium", MOL THER, 4(2), 2001, pp. 115-121
48. Stoll, SM; Sclimenti, CR; Baba, EJ; Meuse, L; Kay, MA; Calos, MP
    Epstein-Barr virus/human vector provides high-level, long-term expression of alpha(1)-antitrypsin in mice
    MOLECULAR THERAPY
    
    S.M. Stoll et al., "Epstein-Barr virus/human vector provides high-level, long-term expression of alpha(1)-antitrypsin in mice", MOL THER, 4(2), 2001, pp. 122-129
49. Dhillon, H; Kalra, SP; Kalra, PS
    Dose-dependent effects of central leptin gene therapy on genes that regulate body weight and appetite in the hypothalamus
    MOLECULAR THERAPY
    
    H. Dhillon et al., "Dose-dependent effects of central leptin gene therapy on genes that regulate body weight and appetite in the hypothalamus", MOL THER, 4(2), 2001, pp. 139-145
50. Chalmers, D; Ferrand, C; Apperley, JF; Melo, JV; Ebeling, S; Newton, I; Duperrier, A; Hagenbeek, A; Garrett, E; Tiberghien, P; Garin, M
    Elimination of the truncated message from the herpes simplex virus thymidine kinase suicide gene
    MOLECULAR THERAPY
    
    D. Chalmers et al., "Elimination of the truncated message from the herpes simplex virus thymidine kinase suicide gene", MOL THER, 4(2), 2001, pp. 146-148
51. Atencio, IA; Avanzini, JB; Johnson, D; Neuteboom, S; Vaillancourt, MT; Nielsen, LL; Hajian, G; Sutjipto, S; Sugarman, BJ; Philopena, J; McAllister, DL; Beltran, JC; Nodelman, M; Ramachandra, M; Wills, KN
    Enhanced apoptotic activity of a p53 variant in tumors resistant to wild-type p53 treatment
    MOLECULAR THERAPY
    
    I.A. Atencio et al., "Enhanced apoptotic activity of a p53 variant in tumors resistant to wild-type p53 treatment", MOL THER, 4(1), 2001, pp. 5-12
52. Croyle, MA; Cheng, X; Sandhu, A; Wilson, JM
    Development of novel formulations that enhance adenoviral-mediated gene expression in the lung in vitro and in vivo
    MOLECULAR THERAPY
    
    M.A. Croyle et al., "Development of novel formulations that enhance adenoviral-mediated gene expression in the lung in vitro and in vivo", MOL THER, 4(1), 2001, pp. 22-28
53. Maron, DJ; Tada, H; Moscioni, AD; Tazelaar, J; Fraker, DL; Wilson, JM; Spitz, FR
    Intra-arterial delivery of a recombinant adenovirus does not increase genetransfer to tumor cells in a rat model of metastatic colorectal carcinoma
    MOLECULAR THERAPY
    
    D.J. Maron et al., "Intra-arterial delivery of a recombinant adenovirus does not increase genetransfer to tumor cells in a rat model of metastatic colorectal carcinoma", MOL THER, 4(1), 2001, pp. 29-35
54. Koehler, DR; Hannam, V; Belcastro, R; Steer, B; Wen, YX; Post, M; Downey, G; Tanswell, AK; Hu, J
    Targeting transgene expression for cystic fibrosis gene therapy
    MOLECULAR THERAPY
    
    D.R. Koehler et al., "Targeting transgene expression for cystic fibrosis gene therapy", MOL THER, 4(1), 2001, pp. 58-65
55. Kyriakides, TR; Hartzel, T; Huynh, G; Bornstein, P
    Regulation of angiogenesis and matrix remodeling by localized, matrix-mediated antisense gene delivery
    MOLECULAR THERAPY
    
    T.R. Kyriakides et al., "Regulation of angiogenesis and matrix remodeling by localized, matrix-mediated antisense gene delivery", MOL THER, 3(6), 2001, pp. 842-849
56. Stein, CS; Kang, Y; Sauter, SL; Townsend, K; Staber, P; Derksen, TA; Martins, I; Qian, J; Davidson, BL; McCray, PB
    In vivo treatment of hemophilia A and mucopolysaccharidosis type VII usingnonprimate lentiviral vectors
    MOLECULAR THERAPY
    
    C.S. Stein et al., "In vivo treatment of hemophilia A and mucopolysaccharidosis type VII usingnonprimate lentiviral vectors", MOL THER, 3(6), 2001, pp. 850-856
57. Vorup-Jensen, T; Jensen, UB; Liu, H; Kawasaki, T; Uemura, K; Thiel, S; Dagnaes-Hansen, F; Jensen, TG
    Tail-vein injection of mannan-binding lectin DNA leads to high expression levels of multimeric protein in liver
    MOLECULAR THERAPY
    
    T. Vorup-Jensen et al., "Tail-vein injection of mannan-binding lectin DNA leads to high expression levels of multimeric protein in liver", MOL THER, 3(6), 2001, pp. 867-874
58. Serguera, C; Sarkis, C; Ridet, JL; Colin, P; Moullier, P; Mallet, J
    Primary adult human astrocytes as an ex vivo vehicle for beta-glucuronidase delivery in the brain
    MOLECULAR THERAPY
    
    C. Serguera et al., "Primary adult human astrocytes as an ex vivo vehicle for beta-glucuronidase delivery in the brain", MOL THER, 3(6), 2001, pp. 875-881
59. Nettelbeck, DM; Miller, DW; Jerome, V; Zuzarte, M; Watkins, SJ; Hawkins, RE; Muller, R; Kontermann, RE
    Targeting of adenovirus to endothelial cells by a bispecific single-chain diabody directed against the adenovirus fiber knob domain and human endoglin (CD105)
    MOLECULAR THERAPY
    
    D.M. Nettelbeck et al., "Targeting of adenovirus to endothelial cells by a bispecific single-chain diabody directed against the adenovirus fiber knob domain and human endoglin (CD105)", MOL THER, 3(6), 2001, pp. 882-891
60. Yao, QP; Wang, SJ; Glorioso, JC; Evans, CH; Robbins, PD; Ghivizzani, SC; Oligino, TJ
    Gene transfer of p53 to arthritic joints stimulates synovial apoptosis andinhibits inflammation
    MOLECULAR THERAPY
    
    Q.P. Yao et al., "Gene transfer of p53 to arthritic joints stimulates synovial apoptosis andinhibits inflammation", MOL THER, 3(6), 2001, pp. 901-910
61. Tan, MQ; Qing, K; Zhou, SZ; Yoder, MC; Srivastava, A
    Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted long-term expression of the human beta-globin gene in hematopoietic cells from homozygous beta-thalassemic mice
    MOLECULAR THERAPY
    
    M.Q. Tan et al., "Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted long-term expression of the human beta-globin gene in hematopoietic cells from homozygous beta-thalassemic mice", MOL THER, 3(6), 2001, pp. 940-946
62. Chen, XW; Frisina, RD; Bowers, WJ; Frisina, DR; Federoff, HJ
    HSV amplicon-mediated neurotrophin-3 expression protects murine spiral ganglion neurons from cisplatin-induced damage
    MOLECULAR THERAPY
    
    X.W. Chen et al., "HSV amplicon-mediated neurotrophin-3 expression protects murine spiral ganglion neurons from cisplatin-induced damage", MOL THER, 3(6), 2001, pp. 958-963
63. Grifman, M; Trepel, M; Speece, P; Gilbert, LB; Arap, W; Pasqualini, R; Weitzman, MD
    Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids
    MOLECULAR THERAPY
    
    M. Grifman et al., "Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids", MOL THER, 3(6), 2001, pp. 964-975
64. Mesika, A; Grigoreva, I; Zohar, M; Reich, Z
    A regulated, NF kappa B-assisted import of plasmid DNA into mammalian cellnuclei
    MOLECULAR THERAPY
    
    A. Mesika et al., "A regulated, NF kappa B-assisted import of plasmid DNA into mammalian cellnuclei", MOL THER, 3(5), 2001, pp. 653-657
65. Mazzolini, G; Narvaiza, I; Bustos, M; Duarte, M; Tirapu, I; Bilbao, R; Qian, C; Prieto, J; Melero, I
    alpha(v)beta(3) integrin-mediated adenoviral transfer of interleukin-12 atthe periphery of hepatic colon cancer metastases induces VCAM-1 expressionand T-cell recruitment
    MOLECULAR THERAPY
    
    G. Mazzolini et al., "alpha(v)beta(3) integrin-mediated adenoviral transfer of interleukin-12 atthe periphery of hepatic colon cancer metastases induces VCAM-1 expressionand T-cell recruitment", MOL THER, 3(5), 2001, pp. 665-672
66. Hecht, N; Pappo, O; Shouval, D; Rose-John, S; Galun, E; Axelrod, JH
    Hyper-IL-6 gene therapy reverses fulminant hepatic failure
    MOLECULAR THERAPY
    
    N. Hecht et al., "Hyper-IL-6 gene therapy reverses fulminant hepatic failure", MOL THER, 3(5), 2001, pp. 683-687
67. Sanftner, LHM; Rendahl, KG; Quiroz, D; Coyne, M; Ladner, M; Manning, WC; Flannery, JG
    Recombinant AAV-mediated delivery of a tet-inducible reporter gene to the rat retina
    MOLECULAR THERAPY
    
    L.H.M. Sanftner et al., "Recombinant AAV-mediated delivery of a tet-inducible reporter gene to the rat retina", MOL THER, 3(5), 2001, pp. 688-696
68. Zhang, Y; Chirmule, N; Gao, GP; Qian, R; Croyle, M; Joshi, B; Tazelaar, J; Wilson, JM
    Acute cytokine response to systemic adenoviral vectors in mice is mediatedby dendritic cells and macrophages
    MOLECULAR THERAPY
    
    Y. Zhang et al., "Acute cytokine response to systemic adenoviral vectors in mice is mediatedby dendritic cells and macrophages", MOL THER, 3(5), 2001, pp. 697-707
69. Weiss, DJ; Bonneau, L; Liggitt, D
    Use of perfluorochemical liquid allows earlier detection of gene expression and use of less vector in normal lung and enhances gene expression in acutely injured lung
    MOLECULAR THERAPY
    
    D.J. Weiss et al., "Use of perfluorochemical liquid allows earlier detection of gene expression and use of less vector in normal lung and enhances gene expression in acutely injured lung", MOL THER, 3(5), 2001, pp. 734-745
70. Sung, RS; Qin, LH; Bromberg, JS
    TNF alpha and IFN gamma induced by innate anti-adenoviral immune responsesinhibit adenovirus-mediated transgene expression
    MOLECULAR THERAPY
    
    R.S. Sung et al., "TNF alpha and IFN gamma induced by innate anti-adenoviral immune responsesinhibit adenovirus-mediated transgene expression", MOL THER, 3(5), 2001, pp. 757-767
71. Akyurek, LM; Nallamshetty, S; Aoki, K; San, H; Yang, ZY; Nabel, GJ; Nabel, EG
    Coexpression of guanylate kinase with thymidine kinase enhances prodrug cell killing in vitro and suppresses vascular smooth muscle cell proliferation in vivo
    MOLECULAR THERAPY
    
    L.M. Akyurek et al., "Coexpression of guanylate kinase with thymidine kinase enhances prodrug cell killing in vitro and suppresses vascular smooth muscle cell proliferation in vivo", MOL THER, 3(5), 2001, pp. 779-786
72. Mackay, IM; Metharom, P; Sloots, TP; Wei, MQ
    Quantitative PCR-ELAHA for the determination of retroviral vector transduction efficiency
    MOLECULAR THERAPY
    
    I.M. Mackay et al., "Quantitative PCR-ELAHA for the determination of retroviral vector transduction efficiency", MOL THER, 3(5), 2001, pp. 801-808
73. Ng, P; Beauchamp, C; Evelegh, C; Parks, R; Graham, FL
    Development of a FLP/frt system for generating helper-dependent adenoviralvectors
    MOLECULAR THERAPY
    
    P. Ng et al., "Development of a FLP/frt system for generating helper-dependent adenoviralvectors", MOL THER, 3(5), 2001, pp. 809-815
74. Carmen, IH
    A death in the laboratory: The politics of the Gelsinger aftermath
    MOLECULAR THERAPY
    
    I.H. Carmen, "A death in the laboratory: The politics of the Gelsinger aftermath", MOL THER, 3(4), 2001, pp. 425-428
75. Nakano, K; Todo, T; Chijiiwa, K; Tanaka, M
    Therapeutic efficacy of G207, a conditionally replicating herpes simplex virus type 1 mutant, for gallbladder carcinoma in immunocompetent hamsters
    MOLECULAR THERAPY
    
    K. Nakano et al., "Therapeutic efficacy of G207, a conditionally replicating herpes simplex virus type 1 mutant, for gallbladder carcinoma in immunocompetent hamsters", MOL THER, 3(4), 2001, pp. 431-437
76. Moutsatsos, IK; Turgeman, G; Zhou, SH; Kurkalli, BG; Pelled, G; Tzur, L; Kelley, P; Stumm, N; Mi, S; Muller, R; Zilberman, Y; Gazit, D
    Exogenously regulated stem cell-mediated gene therapy for bone regeneration
    MOLECULAR THERAPY
    
    I.K. Moutsatsos et al., "Exogenously regulated stem cell-mediated gene therapy for bone regeneration", MOL THER, 3(4), 2001, pp. 449-461
77. Gao, CH; Kennedy, S; Ponder, KP
    Lipopolysaccharide potentiates the effect of hepatocyte growth factor uponreplication in lung, thyroid, spleen, and colon in rats in vivo
    MOLECULAR THERAPY
    
    C.H. Gao et al., "Lipopolysaccharide potentiates the effect of hepatocyte growth factor uponreplication in lung, thyroid, spleen, and colon in rats in vivo", MOL THER, 3(4), 2001, pp. 462-475
78. Larocca, D; Jensen-Pergakes, K; Burg, MA; Baird, A
    Receptor-targeted gene delivery using multivalent phagemid particles
    MOLECULAR THERAPY
    
    D. Larocca et al., "Receptor-targeted gene delivery using multivalent phagemid particles", MOL THER, 3(4), 2001, pp. 476-484
79. Sukin, SW; Chhikara, M; Zhu, XH; Ayala, G; Aguilar, LK; Smith, EO; Miles, BJ; Thompson, TC; Kadmon, D; Aguilar-Cordova, E
    In vivo surgical resection plus adjuvant gene therapy in the treatment of mammary and prostate cancer
    MOLECULAR THERAPY
    
    S.W. Sukin et al., "In vivo surgical resection plus adjuvant gene therapy in the treatment of mammary and prostate cancer", MOL THER, 3(4), 2001, pp. 500-506
80. Green, ES; Rendahl, KG; Zhou, SZ; Ladner, M; Coyne, M; Srivastava, R; Manning, WC; Flannery, JG
    Two animal models of retinal degeneration are rescued by recombinant adeno-associated virus-mediated production of FGF-5 and FGF-18
    MOLECULAR THERAPY
    
    E.S. Green et al., "Two animal models of retinal degeneration are rescued by recombinant adeno-associated virus-mediated production of FGF-5 and FGF-18", MOL THER, 3(4), 2001, pp. 507-515
81. Maijgren-Steffensson, C; Sonnerborg, A; Vahlne, A; Britton, S; Larsson, S; Ahrlund-Richter, L
    Smaller amounts of antiretroviral drugs are needed when combined with an active ribozyme against HIV-1
    MOLECULAR THERAPY
    
    C. Maijgren-Steffensson et al., "Smaller amounts of antiretroviral drugs are needed when combined with an active ribozyme against HIV-1", MOL THER, 3(4), 2001, pp. 531-535
82. Chhikara, M; Huang, HX; Vlachaki, MT; Zhu, XH; Teh, B; Chiu, KJ; Woo, S; Berner, B; Smith, EO; Oberg, KC; Aguilar, LK; Thompson, TC; Butler, EB; Aguilar-Cordova, E
    Enhanced therapeutic effect of HSV-tk plus GCV gene therapy and ionizing radiation for prostate cancer
    MOLECULAR THERAPY
    
    M. Chhikara et al., "Enhanced therapeutic effect of HSV-tk plus GCV gene therapy and ionizing radiation for prostate cancer", MOL THER, 3(4), 2001, pp. 536-542
83. Stover, ML; Wang, CKL; McKinstry, MB; Kalajzic, I; Gronowicz, G; Clark, SH; Rowe, DW; Lichtler, AC
    Bone-directed expression of Col1a1 promoter-driven self-inactivating retroviral vector in bone marrow cells and transgenic mice
    MOLECULAR THERAPY
    
    M.L. Stover et al., "Bone-directed expression of Col1a1 promoter-driven self-inactivating retroviral vector in bone marrow cells and transgenic mice", MOL THER, 3(4), 2001, pp. 543-550
84. Gautam, A; Densmore, CL; Golunski, E; Xu, B; Waldrep, JC
    Transgene expression in mouse airway epithelium by aerosol gene therapy with PEI-DNA complexes
    MOLECULAR THERAPY
    
    A. Gautam et al., "Transgene expression in mouse airway epithelium by aerosol gene therapy with PEI-DNA complexes", MOL THER, 3(4), 2001, pp. 551-556
85. Mendoza, GJA; Seidel, NE; Otsu, M; Anderson, SM; Simon-Stoos, K; Herrera, A; Hoogstraten-Miller, S; Malech, HL; Candotti, F; Puck, JM; Bodine, DM
    Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model
    MOLECULAR THERAPY
    
    G.J.A. Mendoza et al., "Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model", MOL THER, 3(4), 2001, pp. 565-573
86. Chen, RH; Meseck, ML; Woo, SLC
    Auto-regulated hepatic insulin gene expression in type 1 diabetic rats
    MOLECULAR THERAPY
    
    R.H. Chen et al., "Auto-regulated hepatic insulin gene expression in type 1 diabetic rats", MOL THER, 3(4), 2001, pp. 584-590
87. Saeki, Y; Fraefel, C; Ichikawa, T; Breakefield, XO; Chiocca, EA
    Improved helper virus-free packaging system for HSV amplicon vectors usingan ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome
    MOLECULAR THERAPY
    
    Y. Saeki et al., "Improved helper virus-free packaging system for HSV amplicon vectors usingan ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome", MOL THER, 3(4), 2001, pp. 591-601
88. Hughes, C; Galea-Lauri, J; Farzaneh, F; Darling, D
    Streptavidin paramagnetic particles provide a choice of three affinity-based capture and magnetic concentration strategies for retroviral vectors
    MOLECULAR THERAPY
    
    C. Hughes et al., "Streptavidin paramagnetic particles provide a choice of three affinity-based capture and magnetic concentration strategies for retroviral vectors", MOL THER, 3(4), 2001, pp. 623-630
89. Soudais, C; Boutin, S; Kremer, EJ
    Characterization of cis-acting sequences involved in canine adenovirus packaging
    MOLECULAR THERAPY
    
    C. Soudais et al., "Characterization of cis-acting sequences involved in canine adenovirus packaging", MOL THER, 3(4), 2001, pp. 631-640
90. Koch, PE; Guo, ZS; Kagawa, S; Gu, J; Roth, JA; Fang, B
    Augmenting transgene expression from carcinoembryonic antigen (CEA) promoter via a GAL4 gene regulatory system
    MOLECULAR THERAPY
    
    P.E. Koch et al., "Augmenting transgene expression from carcinoembryonic antigen (CEA) promoter via a GAL4 gene regulatory system", MOL THER, 3(3), 2001, pp. 278-283
91. Lipshutz, GS; Gruber, CA; Cao, YA; Hardy, J; Contag, CH; Gaensler, KML
    In utero delivery of adeno-associated viral vectors: Intraperitoneal gene transfer produces long-term expression
    MOLECULAR THERAPY
    
    G.S. Lipshutz et al., "In utero delivery of adeno-associated viral vectors: Intraperitoneal gene transfer produces long-term expression", MOL THER, 3(3), 2001, pp. 284-292
92. Kuzmin, AI; Galenko, O; Eisensmith, RC
    An immunomodulatory procedure that stabilizes transgene expression and permits readministration of E1-deleted adenovirus vectors
    MOLECULAR THERAPY
    
    A.I. Kuzmin et al., "An immunomodulatory procedure that stabilizes transgene expression and permits readministration of E1-deleted adenovirus vectors", MOL THER, 3(3), 2001, pp. 293-301
93. Zavorotinskaya, T; Albritton, LM
    Two point mutations increase targeted transduction and stabilize vector association of a modified retroviral envelope protein
    MOLECULAR THERAPY
    
    T. Zavorotinskaya e L.M. Albritton, "Two point mutations increase targeted transduction and stabilize vector association of a modified retroviral envelope protein", MOL THER, 3(3), 2001, pp. 323-328
94. Ramesh, R; Saeki, T; Templeton, NS; Ji, L; Stephens, LC; Ito, I; Wilson, DR; Wu, Z; Branch, CD; Minna, JD; Roth, JA
    Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector
    MOLECULAR THERAPY
    
    R. Ramesh et al., "Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector", MOL THER, 3(3), 2001, pp. 337-350
95. Frisella, WA; O'Connor, LH; Vogler, CA; Roberts, M; Walkley, S; Levy, B; Daly, TM; Sands, MS
    Intracranial injection of recombinant adeno-associated virus improves cognitive function in a murine model of mucopolysaccharidosis type VII
    MOLECULAR THERAPY
    
    W.A. Frisella et al., "Intracranial injection of recombinant adeno-associated virus improves cognitive function in a murine model of mucopolysaccharidosis type VII", MOL THER, 3(3), 2001, pp. 351-358
96. Donahue, RE; Sorrentino, BP; Hawley, RG; An, DS; Chen, ISY; Wersto, RP
    Fibronectin fragment CH-296 inhibits apoptosis and enhances ex vivo gene transfer by murine retrovirus and human lentivirus vectors independent of viral tropism in nonhuman primate CD34(+) cells
    MOLECULAR THERAPY
    
    R.E. Donahue et al., "Fibronectin fragment CH-296 inhibits apoptosis and enhances ex vivo gene transfer by murine retrovirus and human lentivirus vectors independent of viral tropism in nonhuman primate CD34(+) cells", MOL THER, 3(3), 2001, pp. 359-367
97. Wu, XF; He, YK; Falo, LD; Hui, KM; Huang, L
    Regression of human mammary adenocarcinoma by systemic administration of arecombinant gene encoding the hFlex-TRAIL fusion protein
    MOLECULAR THERAPY
    
    X.F. Wu et al., "Regression of human mammary adenocarcinoma by systemic administration of arecombinant gene encoding the hFlex-TRAIL fusion protein", MOL THER, 3(3), 2001, pp. 368-374
98. Slepushkin, VA; Staber, PD; Wang, GS; McCray, PB; Davidson, BL
    Infection of human airway epithelia with H1N1, H2N2, and H3N2 influenza A virus strains
    MOLECULAR THERAPY
    
    V.A. Slepushkin et al., "Infection of human airway epithelia with H1N1, H2N2, and H3N2 influenza A virus strains", MOL THER, 3(3), 2001, pp. 395-402
99. Chen, ZY; Yant, SR; He, CY; Meuse, L; Shen, S; Kay, MA
    Linear DNAs concatemerize in vivo and result in sustained transgene expression in mouse liver
    MOLECULAR THERAPY
    
    Z.Y. Chen et al., "Linear DNAs concatemerize in vivo and result in sustained transgene expression in mouse liver", MOL THER, 3(3), 2001, pp. 403-410
100. Mazurier, F; Geronimi, F; Lamrissi-Garcia, I; Morel, C; Richard, E; Ged, C; Fontanellas, A; Moreau-Gaudry, F; Morey, M; de Verneuil, H
     Correction of deficient CD34(+) cells from peripheral blood after mobilization in a patient with congenital erythropoietic porphyria
     MOLECULAR THERAPY
     
     F. Mazurier et al., "Correction of deficient CD34(+) cells from peripheral blood after mobilization in a patient with congenital erythropoietic porphyria", MOL THER, 3(3), 2001, pp. 411-417